Treatment of Parkinson's disease with carbidopa, a peripheral decarboxylase inhibitor, and levodopa.
D000368:Aged; D002230:Carbidopa / Q000494:pharmacology*; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology*; D007980:Levodopa / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*
D006834:Hydrazines; D007980:Levodopa; D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases; D002230:Carbidopa